Article
Cell‐free DNA profiling in retinoblastoma patients with advanced intraocular disease: An MSKCC experience
7 Jul 2020
Abstract excerpt
PURPOSE: The enucleation rate for retinoblastoma has dropped from over 95% to under 10% in the past 10 years as a result of improvements in therapy. This reduces access to tumor tissue for molecular profiling, especially in unilateral retinoblastoma, and hinders the confirmation of somatic RB1 mutations necessary for genetic counseling. Plasma cell-free DNA (cfDNA) has provided a platform for noninvasive...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
